BRMS1 and neoplasm: While Soto et al. had previously shown that combined oncogenic changes of p53KD and Krasv12 in HBEC3 cells were insufficient to confer a full malignant phenotype in a mouse model [17], we asked whether the loss of the metastasis suppressor BRMS1 may result in tumor formation.